We are thrilled to share some exciting news: this year, Neuroendocrine Cancer UK will be investing £100,000 into new research, made possible thanks to the incredible generosity, fundraising, and support of our patient community.
In partnership with UKINETS, we will be awarding five research grants across two funding programmes — both designed to accelerate progress, improve care, and ultimately transform the outlook for those living with neuroendocrine cancer.
This milestone is a reflection of everything you make possible: every donation, every event, every conversation and shared experience contributes to pushing research forward.
What’s Being Funded?
Pump-Priming Research Grants
These larger grants will help spark bold, innovative ideas with the potential to create meaningful change in diagnosis, treatment or long-term care.
-
Funding available: Up to three grants of £30,000
-
Who can apply: Any healthcare professional across the UK and Ireland
-
Purpose: To support new and impactful research designed to improve outcomes for people affected by neuroendocrine cancer
-
Deadline: 1st February 2026
These grants help researchers test new ideas — the kind that could one day change clinical practice or lead to larger national or international studies.
Practice-Changing Grants
These smaller but powerful grants are aimed at accelerating improvements in the here-and-now.
-
Funding available: Up to two grants of £5,000
-
Who can apply: Any healthcare professional across the UK and Ireland
-
Purpose: To support practical projects that can improve patient experience and care pathways within 18 months
-
Examples might include:
-
New clinical protocols
-
Patient support tools
-
Service improvements
-
Innovations that help patients feel better supported, informed and understood
-
Why This Matters
Research is essential not just for the future but for improving lives today.
This funding enables clinicians, scientists and care teams to explore new ideas, question the status quo and bring forward solutions that reflect the real-life needs and experiences of people living with neuroendocrine cancer.
Most importantly, this work is driven by partnership — between researchers, healthcare teams, our community, and every person affected by this rare disease.
